Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael J Romanowski

Showing results (31-40 of 36) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 36 results.
Human Mutation|July 27, 2012
Naturally occurring genetic variants of human caspase-1 differ considerably in structure and the ability to activate interleukin-1βHella Luksch, Michael J Romanowski, Osvaldo Chara, et al.
Bioorganic & Medicinal Chemistry|May 30, 2019
Optimization of novel reversible Bruton's tyrosine kinase inhibitors identified using Tethering-fragment-based screensBrian T Hopkins, Eris Bame, Noah Bell, et al.
Bioorganic & Medicinal Chemistry Letters|April 5, 2011
Discovery of a potent and highly selective PDK1 inhibitor via fragment-based drug discoveryDaniel A Erlanson, Joseph W Arndt, Mark T Cancilla, et al.
Bioorganic & Medicinal Chemistry|July 27, 2021
Utilizing structure based drug design and metabolic soft spot identification to optimize the in vitro potency and in vivo pharmacokinetic properties leading to the discovery of novel reversible Bruton's tyrosine kinase inhibitorsBrian T Hopkins, Eris Bame, Noah Bell, et al.
Bioorganic & Medicinal Chemistry Letters|August 6, 2008
Discovery of a potent and selective aurora kinase inhibitorJohan D Oslob, Michael J Romanowski, Darin A Allen, et al.
Bioorganic & Medicinal Chemistry Letters|August 4, 2009
2-Aminobenzimidazoles as potent Aurora kinase inhibitorsMin Zhong, Minna Bui, Wang Shen, et al.
Pageof 4

Showing results (31-40 of 36) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 36 results.
Human Mutation|July 27, 2012
Naturally occurring genetic variants of human caspase-1 differ considerably in structure and the ability to activate interleukin-1βHella Luksch, Michael J Romanowski, Osvaldo Chara, et al.
Bioorganic & Medicinal Chemistry|May 30, 2019
Optimization of novel reversible Bruton's tyrosine kinase inhibitors identified using Tethering-fragment-based screensBrian T Hopkins, Eris Bame, Noah Bell, et al.
Bioorganic & Medicinal Chemistry Letters|April 5, 2011
Discovery of a potent and highly selective PDK1 inhibitor via fragment-based drug discoveryDaniel A Erlanson, Joseph W Arndt, Mark T Cancilla, et al.
Bioorganic & Medicinal Chemistry|July 27, 2021
Utilizing structure based drug design and metabolic soft spot identification to optimize the in vitro potency and in vivo pharmacokinetic properties leading to the discovery of novel reversible Bruton's tyrosine kinase inhibitorsBrian T Hopkins, Eris Bame, Noah Bell, et al.
Bioorganic & Medicinal Chemistry Letters|August 6, 2008
Discovery of a potent and selective aurora kinase inhibitorJohan D Oslob, Michael J Romanowski, Darin A Allen, et al.
Bioorganic & Medicinal Chemistry Letters|August 4, 2009
2-Aminobenzimidazoles as potent Aurora kinase inhibitorsMin Zhong, Minna Bui, Wang Shen, et al.
Pageof 4